Showing 116 of 116on this page. Filters & sort apply to loaded results; URL updates for sharing.116 of 116 on this page
OncoImmune: CD24Fc in COVID treatment - YouTube
Precise O-Glycosylation Site Localization of CD24Fc by LC-MS Workflows ...
(PDF) CD24Fc protects against viral pneumonia in simian ...
(PDF) CD24Fc ameliorates immune-related adverse events while preserving ...
CD24Fc protects against viral pneumonia in simian immunodeficiency ...
CD24Fc ameliorates immune-related adverse events while preserving anti ...
OncoImmune gets approval to trial CD24Fc for Covid-19 in US
Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a ...
A phase 2 trial of CD24Fc for prevention of graft-versus-host disease - PMC
[글로벌-Biz 24] 머크, 코로나 치료제 CD24Fc 공급 위해 온코이뮨 인수 - 글로벌이코노믹
Targeting Danger Associated Molecular Pattern (DAMP) with CD24Fc to ...
A phase 2 trial of CD24Fc for prevention of graft-versus-host disease ...
Genovis » Blog » Localization of O-glycan Sites in CD24Fc by OpeRATOR ...
默沙东收购Oncolmmune：获得首创重组融合蛋白CD24Fc，3期临床治疗COVID-19疗效显著! - 投资专区 - 生物谷
Population dynamics of peripheral blood mononuclear cells from healthy ...
The interaction of CD24 with SIGLEC10 depends on sialylation of CD24 ...
11 COVID-19 therapies you need to know - Drug Discovery and Development
Use of Anti-Mononuclear Antibodies as Therapy for Covid-19
Subcluster analysis of peripheral blood CD4⁺ T cells in COVID-19 ...
CD24-Siglec axis is an innate immune checkpoint against metaflammation ...
科研速递 | 汉腾生物欧洲团队用LC-MS法精确定位CD24Fc融合蛋白的O-糖基化位点_分析_开发_蛋白
EXO-CD 24 Aparece una luz en el tratamiento del Covid 19 – Gestión y ...
Stimulating CD24-Siglec pathway for treatment of inflammatory and ...
Schematic model of CD24–Siglec interactions. CD24 can recognize ...
Frontiers | Danger Signals and Graft-versus-host Disease: Current ...
(PDF) Treatment with soluble CD24 attenuates COVID-19-associated ...
(PDF) Treatment of COVID-19 by CD24FC; a mini-review to the current ...
新冠疫情：294万！昂科免疫启动III期试验，测试世界首创生物药CD24Fc治疗重症COVID-19患者！ - 投资专区 - 生物谷
新冠肺炎治疗大突破：新药可降低50%死亡缩短40%康复期|以色列|新冠肺炎_新浪科技_新浪网
CD24Fc: A Non-Antiviral Biological Immunomodulator for COVID-19 Therapy ...
Could soluble CD24 offer some hope against severe COVID-19?
CD24Fc: an emerging COVID-19 therapy - The Lancet Infectious Diseases
OncoImmune’s SACCOVID™ (CD24Fc) Exhibits Superb Therapeutic Efficacy—A ...
SACCOVID（CD24Fc）治疗重症COVID-19：表现出卓越疗效-MedSci.cn
1st-of-its-kind therapy blocks immune attack after stem-cell transplant ...
OncoImmune’s SACCOVID demonstrates efficacy in Covid-19 trial
Figure compares healthy alveolus (left) to injured alveolus (right ...
Everything you need to know about the COVID-19 therapy trials - The ...
Frontiers | Surprising magic of CD24 beyond cancer
JCI Insight - Siglec-G represses DAMP-mediated effects on T cells
新冠重症患者的希望：華人團隊研發新藥獲FDA特批進臨床III期 - 每日頭條
代谢疾病新靶点：CD24Fc通过抑制炎症改善肥胖和NASH-公司新闻-Athens Research & Technology (ART)
Increased circulating sialidase activity and reduction of SIGLEC10 ...
Dual blockade of CD47 and CD24 signaling using a novel bispecific ...
科研速递 | 汉腾生物欧洲团队用LC-MS法精确定位CD24Fc融合蛋白的O-糖基化位点 - 知乎
苏州昂康免疫CD24融合蛋白在国内申报临床，已在美国获批开展III期临床丨医麦猛爆料 本文由医麦客原创，欢迎分享，转载须授权 2020年8月 ...
Merck inks supply deal with U.S. for investigational COVID-19 therapy ...
CD24也能用于新冠治疗？看看Siglec通路如何发挥作用-公司新闻-北京百普赛斯生物科技股份有限公司
【精品项目】昂科免疫：致力于开发自免病、恶性肿瘤的免疫治疗创新药物_临床
Preserving Sialic Acid-dependent Pattern Recognition by CD24-Siglec G ...
代谢疾病新靶点：CD24Fc通过抑制炎症改善肥胖和NASH - 企业动态 - 丁香通
Leading with Research & Innovation | Dr. Yang Liu
CD24：火热在研新药EXO-CD24，“搭载”外泌体，抵抗COVID-19？_搜狐网
CD24 signalling through macrophage Siglec-10 is a target for cancer ...
CD24-Fc suppression of immune related adverse events in a therapeutic ...
Merck announces supply agreement with US for initial doses of ...
The CD24/Siglec-10 axis. Siglec10 is similar to other immunosuppressant ...
【前沿靶点】别吃我信号“CD24-SIGLEC10”新进展医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Recombinant human CD24 Protein, C-hFc (HEK293) – Bioss
Targeting CD24 in Cancer Immunotherapy
| Inhibition of tumor immune escape by interfering with CD24/Siglec-10 ...
Inhaled CD24-Enriched Exosomes (EXO-CD24) as a Novel Immune Modulator ...
CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma
年终盘点：汉腾生物实现又好又快的跨越式发展_手机新浪网
广州昂科免疫CTLA-4抗体获批临床丨医麦新观察 - 知乎
说一说COVID-19病毒性和非病毒性治疗靶点那些事儿-环球风云-资讯-生物在线
Treatment with soluble CD24 attenuates COVID-19-associated systemic ...
Subcluster analysis of peripheral blood CD8⁺ T cells in COVID-19 ...
Subcluster analysis of peripheral blood NK cells in COVID-19 patients ...
CD24-Siglec interactions in inflammatory diseases - PMC
Siglec-G represses DAMP-mediated effects on T cells - PMC
精诚医药助力广州昂科免疫CD24Fc项目Ⅰ期临床试验顺利开展 - 我的网站
喜讯！广州昂科免疫CD24Fc项目Ⅰ期临床研究首例受试者完成给药
Terapia inédita bloqueia ataque imunológico após transplante de células ...
머크, 온코이뮨 4.25억弗 인수.."코로나19 치료제 개발" - 바이오스펙테이터
Thread by @carol_perelman on Thread Reader App – Thread Reader App
新冠疫情：1.38亿！默沙东终止开发免疫调节剂MK-7110(CD24Fc，Saccovid)用于治疗COVID-19! - 投资专区 - 生物谷
.jpg)
